Piotr Wlaź

Prof. Piotr Wlaź

Department of Animal Physiology and Pharmacology, Institute of Biological Sciences, Maria Curie-Skłodowska University, Akademicka 19, 20-033 Lublin, Poland
orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Pharmacological Research
Verified
Journal Article
Open access
KSKatarzyna Socała
Katarzyna Socała
UDUrszula Doboszewska
Urszula Doboszewska
Aleksandra SzopaAleksandra Szopa
Aleksandra Szopa
ASAnna Serefko
Anna Serefko
MWMarcin Włodarczyk
Marcin Włodarczyk
PWPiotr Wlaź
Piotr Wlaź
Emerging evidence indicates that the gut microbiota play a crucial role in the bidirectional communication between the gut and the brain suggesting that the gut microbes may shape neural development, modulate neurotransmission and affect behavior, and thereby contribute to the pathogenesis and/or progression of many neurodevelopmental, neuropsychiatric, and neurological conditions. This review summarizes recent data on the role of microbiota-gut-brain axis in the pathophysiology of neuropsychiatric and neurological disorders including depression, anxiety, schizophrenia, autism spectrum disorders, Parkinson's disease, migraine, and epilepsy. Also, the involvement of microbiota in gut disorders co-existing with neuropsychiatric conditions is highlighted. We discuss data from both in vivo preclinical experiments and clinical reports including: (1) studies in germ-free animals, (2) studies exploring the gut microbiota composition in animal models of diseases or in humans, (3) studies evaluating the effects of probiotic, prebiotic or antibiotic treatment as well as (4) the effects of fecal microbiota transplantation.

Verified
Journal Article
Open access
PDF file
KSKatarzyna Socała
Katarzyna Socała
Aleksandra SzopaAleksandra Szopa
Aleksandra Szopa
ASAnna Serefko
Anna Serefko
Ewa PoleszakEwa Poleszak
Ewa Poleszak
PWPiotr Wlaź
Piotr Wlaź
Coffee is one of the most widely consumed beverages worldwide. It is usually identified as a stimulant because of a high content of caffeine. However, caffeine is not the only coffee bioactive component. The coffee beverage is in fact a mixture of a number of bioactive compounds such as polyphenols, especially chlorogenic acids (in green beans) and caffeic acid (in roasted coffee beans), alkaloids (caffeine and trigonelline), and the diterpenes (cafestol and kahweol). Extensive research shows that coffee consumption appears to have beneficial effects on human health. Regular coffee intake may protect from many chronic disorders, including cardiovascular disease, type 2 diabetes, obesity, and some types of cancer. Importantly, coffee consumption seems to be also correlated with a decreased risk of developing some neurodegenerative conditions such as Alzheimer’s disease, Parkinson’s disease, and dementia. Regular coffee intake may also reduce the risk of stroke. The mechanism underlying these effects is, however, still poorly understood. This review summarizes the current knowledge on the neuroprotective potential of the main bioactive coffee components, i.e., caffeine, chlorogenic acid, caffeic acid, trigonelline, kahweol, and cafestol. Data from both in vitro and in vivo preclinical experiments, including their potential therapeutic applications, are reviewed and discussed. Epidemiological studies and clinical reports on this matter are also described. Moreover, potential molecular mechanism(s) by which coffee bioactive components may provide neuroprotection are reviewed.

1 March 2009 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Closed access
Bernadeta SzewczykBernadeta Szewczyk
Bernadeta Szewczyk
Ewa PoleszakEwa Poleszak
Ewa Poleszak
PWPiotr Wlaź
Piotr Wlaź
AWAndrzej Wróbel
Andrzej Wróbel
EBEliza Blicharska
Eliza Blicharska
GNGabriel Nowak
Gabriel Nowak

1 May 2004 in Pharmacology Biochemistry and Behavior
Verified
Journal Article
Closed access
Ewa PoleszakEwa Poleszak
Ewa Poleszak
Bernadeta SzewczykBernadeta Szewczyk
Bernadeta Szewczyk
EKEwa Kędzierska
Ewa Kędzierska
PWPiotr Wlaź
Piotr Wlaź
APAndrzej Pilc
Andrzej Pilc
GNGabriel Nowak
Gabriel Nowak

1 May 2013 in Pharmacological Reports
Verified
Journal Article
Closed access
ASAnna Serefko
Anna Serefko
Aleksandra SzopaAleksandra Szopa
Aleksandra Szopa
PWPiotr Wlaź
Piotr Wlaź
GNGabriel Nowak
Gabriel Nowak
MRMaria Radziwoń-Zaleska
Maria Radziwoń-Zaleska
EPEwa Poleszak
Ewa Poleszak

3 December 2009 in Amino Acids
Verified
Journal Article
Closed access
PDF file
Bernadeta SzewczykBernadeta Szewczyk
Bernadeta Szewczyk
EPE. Poleszak
E. Poleszak
MSMagdalena Sowa-Kućma
Magdalena Sowa-Kućma
AWAndrzej Wróbel
Andrzej Wróbel
SSS. Słotwiński
S. Słotwiński
GNGabriel Nowak
Gabriel Nowak